# Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis

> **NCT07535931** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Shenzhen Huishan Biotechnology Co., Ltd.** · enrollment: 21 (estimated)

## Conditions studied

- Systemic Sclerosis (SSc)

## Interventions

- **DRUG:** HS_SW01 cells injection
- **DRUG:** HS_SW01 cells injection
- **DRUG:** HS_SW01 cells injection

## Key facts

- **NCT ID:** NCT07535931
- **Lead sponsor:** Shenzhen Huishan Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07535931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07535931, "Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07535931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*